• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性碘治疗合并泪囊碘潴留的甲状腺癌

Radioactive Iodine Treatment for Thyroid Cancer Complicated by Lacrimal Sac Retention of Iodine.

作者信息

Suresh Annu, Esposito Giuseppe, Davidson Bruce, Doroslovački Pavle, Jonklaas Jacqueline

机构信息

Department of Internal Medicine, Medstar Georgetown University Hospital, Washington, DC 20007, USA.

Department of Nuclear Medicine, Medstar Georgetown University Hospital, Washington, DC 20007, USA.

出版信息

JCEM Case Rep. 2024 Dec 13;3(1):luae234. doi: 10.1210/jcemcr/luae234. eCollection 2025 Jan.

DOI:10.1210/jcemcr/luae234
PMID:39678652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11644468/
Abstract

Patients with intermediate-risk thyroid cancers may undergo treatment with radioactive iodine-131 (I-131). They often undergo a pretreatment diagnostic iodine scan that typically shows areas of physiological uptake in the stomach, bladder, parotid glands as well as thyroid-remnant uptake and sites of metastatic disease. A 48-year-old woman with intermediate-risk papillary thyroid cancer with metastases to lateral compartment lymph nodes was found to have increased retention of iodine in the medial portion of her left orbit on the diagnostic scan. This was suggestive of preexisting nasolacrimal duct stenosis leading to retention of secretions in the lacrimal sac, raising concerns that the I-131 used in treatment would have delayed clearance that could further damage her lacrimal sac and eye. In consultation with ophthalmology, the patient received pretreatment azelastine and prednisolone drops and underwent treatment with radioactive iodine followed by saline lacrimal irrigation. Though she had subsequent eye pain and swelling necessitating repeated irrigation, the patient was able to undergo treatment for her papillary thyroid cancer and retained full function of her eye. This case highlights an approach that could be used for patients with nasolacrimal duct stenosis in whom radioactive iodine treatment is deemed beneficial.

摘要

中危甲状腺癌患者可能会接受放射性碘-131(I-131)治疗。他们通常会在治疗前进行诊断性碘扫描,该扫描通常会显示胃、膀胱、腮腺的生理性摄取区域,以及甲状腺残留摄取和转移病灶部位。一名48岁的中危乳头状甲状腺癌伴侧方淋巴结转移的女性患者,在诊断性扫描中发现其左眼眶内侧碘滞留增加。这提示存在鼻泪管狭窄,导致泪囊分泌物潴留,引发了对治疗中使用的I-131清除延迟可能进一步损害其泪囊和眼睛的担忧。经眼科会诊,患者在治疗前接受了氮卓斯汀和泼尼松龙滴眼液治疗,并在放射性碘治疗后进行了生理盐水泪道冲洗。尽管她随后出现眼痛和肿胀,需要反复冲洗,但该患者能够接受乳头状甲状腺癌的治疗,并且眼睛保留了全部功能。该病例突出了一种可用于放射性碘治疗被认为有益的鼻泪管狭窄患者的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9915/11644468/6985f87baffd/luae234f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9915/11644468/6985f87baffd/luae234f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9915/11644468/6985f87baffd/luae234f1.jpg

相似文献

1
Radioactive Iodine Treatment for Thyroid Cancer Complicated by Lacrimal Sac Retention of Iodine.放射性碘治疗合并泪囊碘潴留的甲状腺癌
JCEM Case Rep. 2024 Dec 13;3(1):luae234. doi: 10.1210/jcemcr/luae234. eCollection 2025 Jan.
2
Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma.与甲状腺癌放射性碘治疗相关的鼻泪管阻塞
Ophthalmic Plast Reconstr Surg. 2003 Nov;19(6):479-81. doi: 10.1097/01.IOP.0000092802.75899.F8.
3
[Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].[甲状腺癌放射性碘治疗相关的泪道引流系统阻塞]
Arq Bras Oftalmol. 2012 Mar-Apr;75(2):97-100. doi: 10.1590/s0004-27492012000200005.
4
Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level.泪道摄取放射性碘-131 与泪液生成量的关系。
Indian J Ophthalmol. 2023 May;71(5):1828-1832. doi: 10.4103/IJO.IJO_2780_22.
5
Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy.放射性碘治疗后酷似转移性甲状腺癌的结节病
J Community Hosp Intern Med Perspect. 2015 Feb 3;5(1):26360. doi: 10.3402/jchimp.v5.26360. eCollection 2015.
6
Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib.达拉非尼和曲美替尼治疗后BRAF V600E突变的放射性碘难治性转移性甲状腺乳头状癌的再分化
Cureus. 2021 Aug 27;13(8):e17488. doi: 10.7759/cureus.17488. eCollection 2021 Aug.
7
Nasolacrimal Duct Obstruction Following Radioactive Iodine: An Update on Counseling Recommendations for Thyroid Cancer Survivors.放射性碘治疗后的鼻泪管阻塞:甲状腺癌幸存者咨询建议的最新情况
Endocr Pract. 2025 Feb;31(2):176-179. doi: 10.1016/j.eprac.2024.11.001. Epub 2024 Nov 9.
8
Accumulation of 131Iodine in the nasolacrimal sac/duct after radioiodine therapy for papillary thyroid cancer.放射性碘治疗甲状腺乳头状癌后 131I 碘在鼻泪囊/管中的蓄积。
J Pak Med Assoc. 2023 Mar;73(3):713-714. doi: 10.47391/JPMA.23-22.
9
Epiphora after radioactive iodine ablation for thyroid cancer.甲状腺癌放射性碘消融术后溢泪
Thyroid. 2013 Feb;23(2):243-5. doi: 10.1089/thy.2011.0186.
10
Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.碘化钠同向转运体在泪道系统中的表达:对接受¹³¹I治疗患者鼻泪管阻塞潜在机制的启示
Ophthalmic Plast Reconstr Surg. 2005 Sep;21(5):337-44. doi: 10.1097/01.iop.0000179369.75569.a8.

本文引用的文献

1
A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears After Radioactive Iodine Treatment for Thyroid Cancer.一项关于甲状腺癌放射性碘治疗后人工泪液对泪液放射性影响的初步非随机对照试验。
Thyroid. 2024 Jan;34(1):82-87. doi: 10.1089/thy.2023.0338. Epub 2023 Dec 11.
2
Surgical Risk Prediction for Nasolacrimal Duct Obstruction in Radioactive Iodine-Treated Thyroid Cancer: A Nationwide Cohort Study.放射性碘治疗甲状腺癌后鼻泪管阻塞的手术风险预测:一项全国性队列研究。
Thyroid. 2022 May;32(5):544-551. doi: 10.1089/thy.2021.0418. Epub 2022 Jan 11.
3
Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology.
分化型甲状腺癌放射性碘治疗后的唾液腺和泪腺功能障碍:美国头颈协会内分泌外科学组和唾液腺学组关于耳鼻喉科、眼科、核医学和内分泌学的多学科联合临床共识声明
Head Neck. 2020 Nov;42(11):3446-3459. doi: 10.1002/hed.26417. Epub 2020 Aug 19.
4
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
5
Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases.分化型甲状腺癌放射性碘131治疗后鼻泪管阻塞:19例病例回顾
Clin Ophthalmol. 2014 Dec 5;8:2479-84. doi: 10.2147/OPTH.S71708. eCollection 2014.
6
Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.放射性碘治疗后的鼻部症状:一种很少被描述的副作用,其发生率与泪腺功能障碍相似。
Thyroid. 2014 Dec;24(12):1806-14. doi: 10.1089/thy.2014.0162.
7
The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer.分化型甲状腺癌患者在进行碘131消融治疗前放射性碘扫描的效用。
Thyroid. 2009 Aug;19(8):849-55. doi: 10.1089/thy.2008.0419.
8
Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial.S-2-(3-氨丙基氨基)乙硫代磷酸(氨磷汀)在高剂量放射性碘治疗中对唾液腺的保护作用:在兔动物模型及双盲多臂试验中获得的结果
Cancer Biother Radiopharm. 1999 Oct;14(5):337-47. doi: 10.1089/cbr.1999.14.337.